HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,029-2,040 of 7,264
Drug study icon
CompletedEUCTR 2010-024198-38

A long-term, open-label, flexible-dose, extension study evaluating the safety and tolerability of Lu AA21004 (15 and 20 mg/day) in patients with Major Depressive Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Estonia, Finland, + 3 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2011-006121-26

A Multicenter, Double-Blind, Placebo-Controlled Study of JNJ-40411813 as Adjunctive Treatment to an Antidepressant in Adults with Major Depressive Disorder with Anxiety Symptoms

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, AnxietyHistorical research record
Countries
Bulgaria, Hungary, Slovakia
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2012-001950-25

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Study with Vilazodone in Patients with Major Depressive Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
Bulgaria, Finland, Germany
Sponsor
Forest Research Institute, Inc., a wholly owned subsidiary of Forest Laboratories, Inc.
Drug study icon
CompletedEUCTR 2019-002704-41

A randomised, double-blind, parallel-group, active controlled study evaluating the efficacy of vortioxetine versus desvenlafaxine in adult patients suffering from major depressive disorder with par...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Bulgaria, Czechia, + 4 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2017-005149-64

A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (5.0 mg or 2.5 mg) of MIN-117 in Adult Patients with Major Depressive Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
Bulgaria, Finland, Poland
Sponsor
Minerva Neurosciences, Inc

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.